A Study of Safety and Pharmacokinetics of Volitinib With Docetaxel in Patients With Advanced Gastric Cancer
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and tolerability of volitinib in
combination with docetaxel in patients with locally advanced or metastatic gastric cancer and
to determine the Maximum tolerated dose (MTD) and/or recommended phase II dose (RP2D) of
volitinib in combination with docetaxel.